Advertisement

Operative Verfahren bei Präkanzerosen und In-Situ-Karzinom

  • S. F. Schoppmann
  • D. Kandioler
  • R. Horvat
Chapter
  • 829 Downloads

Auszug

Die Mastopathie ist die häufigste gutartige Veränderung der weiblichen Brust. Mehr als die Hälfte aller Frauen ist im Lauf ihres Lebens mehr oder weniger stark von dieser Schwellung oder Verhärtung des Brustdrüsengewebes betroffen. Bei ausgeprägten Formen einer Mastopathie machen sich viele Frauen Sorgen wegen eines erhöhten Brustkrebsrisikos. In den meisten Fällen gibt es jedoch keinen Anlass zu großer Beunruhigung.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bobrow LG et al. (1994) The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol 11: 199–207PubMedGoogle Scholar
  2. Carter D, Smith RL (1977) Carcinoma in situ of the breast. Cancer 40: 1189–1193PubMedCrossRefGoogle Scholar
  3. Fisher B et al. (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328: 1581–1586PubMedCrossRefGoogle Scholar
  4. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E (1995) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B17. Cancer 75: 13109Google Scholar
  5. Heywang-Köbrunner SH, Schreer I (1996) Bildgebende Mammadiagnostik, Untersuchungstechnik, Befundmuster und Differentialdiagnostik in der Mammographie. Thieme, Stuttgart New YorkGoogle Scholar
  6. Holland R et al. (1990) Extent, distribution, and mammographic/histologic correlations of breast ductal carcinoma in situ. Lancet 335: 519–522PubMedCrossRefGoogle Scholar
  7. Holland R et al. (1994) Ductal carcinoma in situ. A proposal for a new classification. Semin Diagn Pathol 11: 167–180PubMedGoogle Scholar
  8. Jackson PA et al. (1994) A comparison of large block macrosectioning and conventional techniques in breast pathology. Virchows Arch 425: 243–248PubMedCrossRefGoogle Scholar
  9. Lagios MD et al. (1982) Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50: 1309–1314PubMedCrossRefGoogle Scholar
  10. Lagios MD et al. (1989) Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local re-currence. Cancer 63: 618–624PubMedCrossRefGoogle Scholar
  11. Lagios MD et al. (1995) Ductal carcinoma in situ: controversies in diagnosis, biology, and treatment. Breast J 1: 68–78CrossRefGoogle Scholar
  12. Lagios MD et al. (1996) Duct carcinoma in situ: biological implications for clinical practice. Semin Oncol 23: 6–11PubMedGoogle Scholar
  13. Lanyi M (1986) Diagnostik und Differentialdiagnostik der Mammaverkalkungen. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  14. Lennington WJ et al. (1994) Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 73:118–124PubMedCrossRefGoogle Scholar
  15. Micale MA et al. (1994) Chromosomal aneuploidy in proliferative breast disease. Hum Pathol 25: 29–35PubMedCrossRefGoogle Scholar
  16. Patchefsky AS et al. (1989) Heterogeneity of intraductal carcinoma of the breast. Cancer 63: 731–741PubMedCrossRefGoogle Scholar
  17. Peters A et al. (1996) Duktales In-situ-Karzinom — Rezidiv und Korrelation mit histomorphologischen Befunden. Verh Dtsch Ges Pathol 80: 288–292Google Scholar
  18. Poller DN et al. (1994) Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 7: 257–262PubMedGoogle Scholar
  19. Riethdorf L et al. (1997) Differential expression of CD66a (BGP), a cell adhesion molecule of the carcinoembryonic antigen family, in benign, premalignant and malignant lesions of the human mammary gland. J Histochem Cytochem 45:957–963PubMedGoogle Scholar
  20. Rosen PP, Snyder RE, Robbins G (1974) Specimen radiography for nonpalpable breast lesions found by mammography. Procedures and results. Cancer 34: 2028–2033PubMedCrossRefGoogle Scholar
  21. Rosen PP et al. (1979) Noninvasive breastcarcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg 139: 377–382CrossRefGoogle Scholar
  22. Shah JP et al. (1973) Pitfalls of local excision in the treatment of carcinoma of the breast. Surg Gynecol Obstet 136:721–725PubMedGoogle Scholar
  23. Silverstein MJ et al. (1994) Can intraductal breast carcinoma be excised completely by local excision? Cancer 73:2985–2989PubMedCrossRefGoogle Scholar
  24. Silverstein MJ, Poller DN, Waisman JR et al. (1995) Prognostic classification of breast ductal carcinoma in situ. Lancet 345: 11547Google Scholar
  25. Silverstein MJ et al. (1996 a) Intraductal breast carcinoma: experiences from the Breast Center in Van Nuys, California. Recent Results Cancer Res 140: 139–153PubMedGoogle Scholar
  26. Silverstein MJ et al. (1996 b) A prognostic index for ductal carcinoma in situ of the breast. Cancer 77: 2267–2274PubMedCrossRefGoogle Scholar
  27. Silverstein MJ, Lagios MD, Waisman JR et al. (1998) Margin width: a critical determinant of local control in patients with ductal carcinoma in situ (DCIS) of the breast. Proc ASCO 17: 120aGoogle Scholar
  28. Silverstein et al. (1999) N Eng J Med 340: 1455CrossRefGoogle Scholar
  29. Solin LJ, Kurtz J, Fourquet A et al. (1996) Fifteen year results of breast conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14: 75463Google Scholar
  30. Stegner HE (1986) Histopathologie der Mammatumoren. Enke, StuttgartGoogle Scholar

Copyright information

© Springer-Verlag / Wien 2007

Authors and Affiliations

  • S. F. Schoppmann
    • 1
  • D. Kandioler
    • 1
  • R. Horvat
    • 2
  1. 1.Brustambulanz AKH Wien, Universitätsklinik für ChirurgieMedizinische Universität WienWien
  2. 2.Klinisches Institut für PathologieMedizinische Universität WienWien

Personalised recommendations